Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:18 AM
Ignite Modification Date:
2025-12-25 @ 4:18 AM
NCT ID:
NCT00564720
Eligibility Criteria:
Inclusion Criteria:
* Histologically confirmed pancreatic cancer.
* Measurable disease.
* Absence of ascites or obstructive jaundice.
* ECOG Performance Status 0-2.
* Adequate liver kidney and bone marrow function.
* Written informed consent.
Exclusion Criteria:
* Chronic diarrheic syndrome.
* Uncontrolled brain metastases after radiation.
* Liver infiltration over 50%.
* Peripheral neuropathy ≥ 2.
* No second primary malignancy within the past 5 years, except non-melanomas skin cancer or in situ carcinoma of the cervix.
* No active uncontrolled infection.
* Active cardiac disease : unstable angina or onset of angina within last 3 months, myocardial infarction within 6 months, congestive heart failure \> class II, cardiac ventricular arrhythmias requiring anti-arrhythmic therapy.
* Women who are pregnant or lactating.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT00564720
Study Brief:
Protocol Section:
NCT00564720